COMP <GO>
ARDT vs MD // EV/EBITDA & P/E VALUATION
Ardent Health Inc. (NYSE) VS. Pediatrix Medical Group Inc. (NYSE) • 15-METRIC TALLY: ARDT 2
— MD 3
■ METRIC PARITY
LAST: $12.30 (+3.10%) • MKT CAP: $1.73B
valuation
—
LAST: $29.18 (+0.93%) • MKT CAP: $2.37B
valuation
9.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARDT VS. MD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARDT | MD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.50% | 33.60% | -23.10 | MD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 9.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 11.43% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 2.10% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 6.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | ARDT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.6 | 71.7 | -14.02 | MD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.9x | 13.3x | -1.40 | ARDT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.73B | $2.37B | -$636.1M | MD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARDT REV | MD REV | ARDT GROSS % | MD GROSS % | ARDT FCF | MD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.32B | $0 | — | — | $470.5M | $271.1M |
| FY 2024 | $5.97B | $0 | — | — | $315.0M | $206.6M |
| FY 2023 | $5.41B | $0 | — | — | $221.7M | $137.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARDT // BETA —
MD // BETA —